NYSE · MET
MetLife, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for MET: Nov 04, 2026
MetLife, Inc. Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is $2.71. The reported EPS for the same quarter last year was $2.34.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $2.71 | $2.84 | $2.60 | 8 |
| Dec 2026 | $2.62 | $2.66 | $2.52 | 7 |
| Mar 2027 | $2.57 | $2.75 | $2.39 | 6 |
| Jun 2027 | $2.80 | $2.92 | $2.63 | 6 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · BNK Invest- Zacks · 3 h agoSeeking Clues to MetLife (MET) Q3 Earnings? A Peek Into Wall Street Projections for Key MetricsEvaluate the expected performance of MetLife (MET) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- Zacks · Oct 29, 6:45 AM EDTHippo Holdings Inc. (HIPO) Tops Q3 Earnings and Revenue EstimatesHippo Holdings (HIPO) delivered earnings and revenue surprises of +54.17% and +0.87%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 28, 9:00 AM EDTRadian (RDN) Earnings Expected to Grow: Should You Buy?Radian (RDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 26, 12:05 PM EDT5 Insurance Stocks That Are Set for Q3 Earnings OutperformanceSolid retention, renewals, prudent pricing, exposure growth and improved digitization are expected to help RNR, MET, PRI, RYAN and UNM outperform Q3 estimates.
- Zacks · Oct 26, 10:08 AM EDTWhat's in the Cards for Willis Towers This Earnings Season?WTW's third quarter is expected to have benefited from strong Health demand, retirement consulting, client retention and technology sales, despite rising expenses.
- Zacks · Oct 21, 7:55 AM EDTWhy Investors Need to Take Advantage of These 2 Finance Stocks NowWhy investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- Zacks · Oct 20, 7:58 AM EDTThe Zacks Analyst Blog Highlights Sun Life Financial, Coca-Cola, Altria, Keurig Dr Pepper and MetLifeSun Life Financial, Coca-Cola, Altria, Keurig Dr Pepper and MetLife offer low-beta, dividend-paying profiles as market volatility returns.
- Zacks · Oct 19, 8:32 AM EDTMetLife's ChatGPT Integration Opens a New Pet Insurance Growth AvenueMET expands its pet insurance reach through ChatGPT, simplifying coverage exploration and quotes while targeting growing demand for affordable pet care.
- Zacks · Oct 19, 7:20 AM EDTBuy 5 Stocks to Stay Safe as Volatility Reappears on Wall StreetVolatility is back as inflation, geopolitical tensions and AI spending concerns mount. SLF, KO, MO, KDP and MET are five low-beta, high-yield stocks to consider for the rest of 2026.
- BNK Invest · Oct 16, 4:01 PM EDTMetLife's Preferred Stock, Series A Crosses Above 6% Yield TerritoryIn trading on Friday, shares of MetLife Inc's Floating Rate Non-Cumulative Preferred Stock, Series A (Symbol: MET.PRA) were yielding above the 6% mark based on its quarterly dividend (annualized to $1.2589), with shares changing hands as low as $20.72 on the day. This compare
- Zacks · Oct 15, 9:29 AM EDTCan Neptune Insurance Beat Q3 Earnings on Higher Policies in Force?Can NP beat Q3 earnings estimates? More policies in force, rising commission income and stronger productivity could help offset higher costs.
- BNK Invest · Oct 14, 3:22 PM EDTMetLife's Preferred Stock, Series F Yield Pushes Past 7%In trading on Wednesday, shares of MetLife Inc's 4.75% Depositary Shares Non-Cumulative Preferred Stock, Series F (Symbol: MET.PRF) were yielding above the 7% mark based on its quarterly dividend (annualized to $1.1875), with shares changing hands as low as $16.82 on the day.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for MetLife, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.